Differentiated Thyroid Carcinoma: Risk Group Assignment and Management Controversies
ByPascal Fuchshuber, MD, PhD,Thom R. Loree, MD, FACS,Mark D. Delacure, MD,Wesley L. Hicks, Jr, DDS, MD, FACS
Published: | Updated:
In this review, we provide a framework for clinical decision-making in the treatment of differentiated thyroid cancer. The clinical discussion and treatment recommendations are relevant to an adult population (more than 16